Firm
Transactions specialists at Paul Weiss are advising on the high-profile split of Kraft Heinz into two companies, while Skadden is also involved in the deal
Youngmin Park joins us for our ‘Five minutes with’ series to discuss learning languages, moonlighting as a drummer, and why late is better than never
The record-breaking $1.5 billion settlement between the AI company and book authors may not lead to rapid resolution of other cases, say copyright lawyers
Leaders at two Brazilian law firms outline strategies to adjust to trademark fee changes at Brazil's IP office while urging clients to apply before September 20
Sponsored
Sponsored
-
Sponsored by ZaccoManaging IP sat down with Patrik Lindahl of Zacco and Alessandra Vercelloni of OpSec to learn about the often-overlooked threat to brands posed by the grey market and parallel imports -
Sponsored by CASPrior art searches play a critical role in shaping effective scientific intellectual property strategies. This article, originally published by CAS, highlights the importance of thorough analysis to safeguard R&D investments and ensure patentability
-
Sponsored by CASJoin Managing IP and CAS at 3pm GMT (4pm CET) on December 4 to hear scientific intellectual property search experts explain how a tailored freedom-to-operate analysis can help avoid infringement and facilitate the path to market
-
Sponsored by Tahota Law FirmCharles Feng of Tahota Law Firm begins a two-part guide to intellectual property protection in China by considering the general provisions, before focusing on the key issues and legal framework concerning trademarks
-
Sponsored by Tahota Law FirmCharles Feng of Tahota Law Firm concludes a two-part series on intellectual property protection in China by looking at copyright, unfair competition, and a change to the appeals procedure for technology-related disputes
-
Sponsored by Maiwald Intellectual PropertyChristian Meyer and Gisela Grabow of Maiwald discuss potential changes to the EU pharmaceutical regulation and their potential impact on data and market protection timelines for medicinal products
